Browse Category

Earnings Reports News 9 January 2026

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity shares dropped 2.9% to $95.64 Friday after Goldman Sachs downgraded the stock to sell and set an $89 target. The move followed HealthEquity’s raised fiscal 2026 revenue outlook and a report of $34.4 billion in HSA assets. KeyBanc maintained an Overweight rating and lifted its price target to $125. The stock fell as the S&P 500 and Nasdaq 100 rose.
P&G stock edges up after Crest kids toothpaste deal; TD Cowen trims target ahead of Jan. 22 earnings

P&G stock edges up after Crest kids toothpaste deal; TD Cowen trims target ahead of Jan. 22 earnings

Procter & Gamble agreed to change Kid’s Crest toothpaste packaging and marketing after pressure from Texas Attorney General Ken Paxton, who cited concerns over dosing for children. New labels began rolling out Jan. 1, with P&G required to comply for five years. Shares rose 0.3% to $141.92 Friday. A private lawsuit over Kid’s Crest labels remains active in Chicago.
MakeMyTrip stock slides 4.5% in U.S. trade as investors turn to Jan. 22 earnings

MakeMyTrip stock slides 4.5% in U.S. trade as investors turn to Jan. 22 earnings

MakeMyTrip shares fell 4.5% to $78.78 in Friday afternoon trading, underperforming U.S.-listed travel peers. The stock hit a session high of $83.42 before sliding, with no new company updates ahead of its expected Jan. 22 earnings. Trading volume reached about 577,000 shares by mid-session. The drop puts MakeMyTrip near its lowest levels since early January.
WD-40 stock slides 6% after Q1 profit falls; guidance held and Asia rebound in focus

WD-40 stock slides 6% after Q1 profit falls; guidance held and Asia rebound in focus

WD-40 shares dropped 5.6% to $192.13 after reporting a first-quarter profit decline and higher expenses, with the stock hitting a session low near $175. Net sales rose 1% to $154.4 million, but diluted EPS fell to $1.28 from $1.39. Management reaffirmed full-year guidance and blamed weak distributor markets for the profit slip. Investors await more detail at the Jan. 13 ICR Conference.
Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Seagate Technology rose 5.4% to $299.92 after Goldman Sachs raised its price target to $310, citing strong 2026 pricing forecasts. The gain followed a 7.7% drop the previous day. A U.S. appeals court revived Seagate’s antitrust claims against NHK Spring late Thursday. Seagate’s next earnings report is expected around Jan. 20, though the date is unconfirmed.
Citigroup stock ticks up as CPI, Citi earnings set next test

Citigroup stock ticks up as CPI, Citi earnings set next test

Citigroup shares gained 0.8% to $121.53 Friday as investors awaited next week’s U.S. bank earnings and December inflation data. Citigroup will report fourth-quarter results Wednesday, following JPMorgan’s release Tuesday. Analysts expect a 32% profit jump for Citi, citing stronger capital markets. The December Consumer Price Index is due Tuesday at 8:30 a.m. ET.
Goldman Sachs stock edges up after Apple Card exit adds $0.46 to Q4 EPS — what to watch next

Goldman Sachs stock edges up after Apple Card exit adds $0.46 to Q4 EPS — what to watch next

Goldman Sachs shares rose 0.5% midday after confirming a deal to transfer the Apple Card program to JPMorgan Chase, moving over $20 billion in balances. The exit is expected to add $0.46 to Q4 EPS, with gains from loan-loss reserve releases offset by write-downs and contract costs. Investors await Goldman's Jan. 15 earnings for details on deal fees and trading. The Apple Card transition remains subject to regulatory approval.
AppLovin Corporation stock jumps as Wells Fargo lifts target ahead of Feb. 11 earnings

AppLovin Corporation stock jumps as Wells Fargo lifts target ahead of Feb. 11 earnings

AppLovin shares jumped 4.4% to $643.44 midday Friday after Wells Fargo raised its price target to $735 and reiterated an Overweight rating. The move outpaced gains in the Nasdaq and broader tech sector. AppLovin will report fourth-quarter and full-year results on Feb. 11 after market close. Investors are watching ad demand trends and upcoming Fed policy signals.
Lockheed Martin stock jumps as Trump order targets defense buybacks and dividends; earnings next

Lockheed Martin stock jumps as Trump order targets defense buybacks and dividends; earnings next

Lockheed Martin shares rose 4.2% to $539.96 Friday after President Trump signed an executive order tying dividends, buybacks, and executive pay to weapons delivery schedules. Defense stocks gained as Trump called for a $1.5 trillion 2027 military budget, far above the $901 billion set for 2026. Lockheed paid $2.3 billion each in dividends and buybacks last year. The company reports quarterly results Jan. 29.
Exxon Mobil (XOM) stock ticks up as filing flags up to $1.2 bln Q4 upstream hit

Exxon Mobil (XOM) stock ticks up as filing flags up to $1.2 bln Q4 upstream hit

Exxon Mobil shares rose 0.6% to $123.63 after warning lower crude prices may cut Q4 upstream earnings by $800 million to $1.2 billion, partly offset by stronger refining margins. Chevron gained 1.4% as oil prices climbed on supply concerns. Exxon also signed a memorandum with Turkey’s TPAO for exploration in the Black Sea and Mediterranean. Investors await Exxon’s Q4 results on Jan. 30.
JPMorgan stock today: Apple Card deal puts JPM in the spotlight as earnings near

JPMorgan stock today: Apple Card deal puts JPM in the spotlight as earnings near

JPMorgan Chase shares rose 0.4% to $331.12 after agreeing to take over Apple Card issuance from Goldman Sachs, a transition expected to move over $20 billion in balances and take about two years pending regulatory approval. JPMorgan will book a $2.2 billion credit-loss provision in Q4. Financial sector ETFs were little changed. Investors await JPMorgan’s Jan. 13 earnings for signals on credit costs and expenses.
1 102 103 104 105 106 202

Stock Market Today

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
Go toTop